{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Famindr.com%2Fepisodes%2F85-fluid-biomarkers-part-1-september-2020-IiKCnvOa","width":444,"version":"1.0","type":"rich","title":"85 - Fluid Biomarkers for Alzheimer's Disease Part 1: September 2020","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/9a8ef428-72db-47cb-a5cb-a6a258a13785/0f815250-ce90-47ab-a2b4-816ce50f3661/slide68.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/31075e38-c7e5-43fe-b1b8-a4e3a779951a\" height=\"200\" width=\"100%\" title=\"85 - Fluid Biomarkers for Alzheimer&apos;s Disease Part 1: September 2020\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"Interested in the mission to accurately diagnose Alzheimer’s disease with a blood test? This episode is perfect for you. In this two-part episode on Fluid Biomarkers in AD from September 2020 papers, Elyn explains the ATN framework for AD diagnosis, and covers papers focused on fluid biomarkers relating to amyloid, tau, and neurodegeneration. She also touches on a few new methods for biomarkers researchers. Tune in to hear about how storage conditions can affect measurements, how assay platforms compare, and new methods for isolating exosomes! \n\nSections in this episode: \nCombination of the Classics: 3:44 \nAmyloid beta: 16:45 \nNeurofilament Light:  22:32 \nMethods: 23:50 "}